Kristen Hege - 1st CAR #Tcell clinical trials in late '90's, this one in #cancer Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer https://t.co/VWNAJNHWvQ
RT @sitcancer: For National Colorectal Cancer Awareness Month, read this #JITC award-winning article from March '17: Safety, tumor traffick…
For National Colorectal Cancer Awareness Month, read this #JITC award-winning article from March '17: Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer https://t.co/S1CwKo2nvT
Scientists discover the potential utility of Chimeric Antigen Receptor T-cells (CAR-T) in the treatment of metastatic colorectal cancer, via the targeting of Tumor-Associated Glycoprotein. https://t.co/AR6TZ668wD @R_Ulbricht #BMS525
RT @sitcancer: For National Colorectal Cancer Awareness Month, read this #JITC award-winning article from March '17: Safety, tumor traffick…
RT @sitcancer: For National Colorectal Cancer Awareness Month, read this #JITC award-winning article from March '17: Safety, tumor traffick…
RT @sitcancer: For National Colorectal Cancer Awareness Month, read this #JITC award-winning article from March '17: Safety, tumor traffick…
For National Colorectal Cancer Awareness Month, read this #JITC award-winning article from March '17: Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer https://t.co/S1CwKo2nvT
RT @sitcancer: For National Colorectal Cancer Awareness Month, read this #JITC award-winning article from March '17: Safety, tumor traffick…
For National Colorectal Cancer Awareness Month, read this #JITC award-winning article from March '17: Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer https://t.co/S1CwKo2nvT
RT @BLLPHD: First CAR trial in cancer, from 1990s published just this year https://t.co/SDw80YMLOU https://t.co/tna0IycgrL
RT @BLLPHD: First CAR trial in cancer, from 1990s published just this year https://t.co/SDw80YMLOU https://t.co/tna0IycgrL
RT @BLLPHD: First CAR trial in cancer, from 1990s published just this year https://t.co/SDw80YMLOU https://t.co/tna0IycgrL
RT @BLLPHD: First CAR trial in cancer, from 1990s published just this year https://t.co/SDw80YMLOU https://t.co/tna0IycgrL
RT @BLLPHD: First CAR trial in cancer, from 1990s published just this year https://t.co/SDw80YMLOU https://t.co/tna0IycgrL
RT @BLLPHD: First CAR trial in cancer, from 1990s published just this year https://t.co/SDw80YMLOU https://t.co/tna0IycgrL
First CAR trial in cancer, from 1990s published just this year https://t.co/SDw80YMLOU https://t.co/tna0IycgrL
Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-7... https://t.co/M9mMceuM3X #jitc
RT @sitcancer: #JITC: Safety, tumor trafficking & immunogenicity chimeric antigen receptor (CAR)-T cells for TAG-72 in colorectal https://t…
RT @sitcancer: #JITC: Safety, tumor trafficking & immunogenicity chimeric antigen receptor (CAR)-T cells for TAG-72 in colorectal https://t…
#JITC: Safety, tumor trafficking & immunogenicity chimeric antigen receptor (CAR)-T cells for TAG-72 in colorectal https://t.co/pNhGA8Osqa https://t.co/MidfaWQYpv
RT @sitcancer: #JITC: Safety, tumor trafficking & immunogenicity chimeric antigen receptor (CAR)-T cells for TAG-72 in colorectal https://t…
RT @sitcancer: #JITC: Safety, tumor trafficking & immunogenicity chimeric antigen receptor (CAR)-T cells for TAG-72 in colorectal https://t…
#JITC: Safety, tumor trafficking & immunogenicity chimeric antigen receptor (CAR)-T cells for TAG-72 in colorectal https://t.co/pNhGA8Osqa https://t.co/kv8ZoFF09T
RT @sitcancer: #JITC: Safety, tumor trafficking & immunogenicity chimeric antigen receptor (CAR)-T cells for TAG-72 in colorectal https://t…
RT @sitcancer: #JITC: Safety, tumor trafficking & immunogenicity chimeric antigen receptor (CAR)-T cells for TAG-72 in colorectal https://t…
#JITC: Safety, tumor trafficking & immunogenicity chimeric antigen receptor (CAR)-T cells for TAG-72 in colorectal https://t.co/pNhGA8Osqa https://t.co/Une30MQW93
RT @BLLPHD: First ever CAR T cell trial in cancer published after 20 years. Credit Cell Genesys team and investigators https://t.co/9Un142…
RT @BLLPHD: First ever CAR T cell trial in cancer published after 20 years. Credit Cell Genesys team and investigators https://t.co/9Un142…
RT @sitcancer: #JITC: Safety, tumor trafficking & immunogenicity chimeric antigen receptor (CAR)-T cells for TAG-72 in colorectal https://t…
#JITC: Safety, tumor trafficking & immunogenicity chimeric antigen receptor (CAR)-T cells for TAG-72 in colorectal https://t.co/pNhGA8Osqa https://t.co/JEVhNPyPoN
RT @sitcancer: #JITC: Safety, tumor trafficking & immunogenicity chimeric antigen receptor (CAR)-T cells for TAG-72 in colorectal https://t…
RT @BLLPHD: First ever CAR T cell trial in cancer published after 20 years. Credit Cell Genesys team and investigators https://t.co/9Un142…
RT @sitcancer: #JITC: Safety, tumor trafficking & immunogenicity chimeric antigen receptor (CAR)-T cells for TAG-72 in colorectal https://t…
RT @BLLPHD: First ever CAR T cell trial in cancer published after 20 years. Credit Cell Genesys team and investigators https://t.co/9Un142…
RT @cells_nnm: Results of the first ever CAR-T cell clinical trials (colorectal cancer), conducted in 1997 are published 20 years later! @B…
RT @cells_nnm: Results of the first ever CAR-T cell clinical trials (colorectal cancer), conducted in 1997 are published 20 years later! @B…
RT @sitcancer: #JITC: Safety, tumor trafficking & immunogenicity chimeric antigen receptor (CAR)-T cells for TAG-72 in colorectal https://t…
RT @BLLPHD: First ever CAR T cell trial in cancer published after 20 years. Credit Cell Genesys team and investigators https://t.co/9Un142…
RT @cells_nnm: Results of the first ever CAR-T cell clinical trials (colorectal cancer), conducted in 1997 are published 20 years later! @B…
RT @BLLPHD: First ever CAR T cell trial in cancer published after 20 years. Credit Cell Genesys team and investigators https://t.co/9Un142…
RT @drkomanduri: By my @UCSFCancer co-fellow and one-time labmate Kristen Hege. Congrats at long last! #Immunotherapy https://t.co/5ftwiv2O…
By my @UCSFCancer co-fellow and one-time labmate Kristen Hege. Congrats at long last! #Immunotherapy https://t.co/5ftwiv2Oej
RT @BLLPHD: First ever CAR T cell trial in cancer published after 20 years. Credit Cell Genesys team and investigators https://t.co/9Un142…
RT @BLLPHD: First ever CAR T cell trial in cancer published after 20 years. Credit Cell Genesys team and investigators https://t.co/9Un142…
RT @BLLPHD: First ever CAR T cell trial in cancer published after 20 years. Credit Cell Genesys team and investigators https://t.co/9Un142…
First ever CAR T cell trial in cancer published after 20 years. Credit Cell Genesys team and investigators https://t.co/9Un142VGPT
RT @sitcancer: #JITC: Safety, tumor trafficking & immunogenicity chimeric antigen receptor (CAR)-T cells for TAG-72 in colorectal https://t…
Results of the first ever CAR-T cell clinical trials (colorectal cancer), conducted in 1997 are published 20 years later! @BLLPHD https://t.co/NUgemIuOQW
RT @sitcancer: #JITC: Safety, tumor trafficking & immunogenicity chimeric antigen receptor (CAR)-T cells for TAG-72 in colorectal https://t…
RT @sitcancer: #JITC: Safety, tumor trafficking & immunogenicity chimeric antigen receptor (CAR)-T cells for TAG-72 in colorectal https://t…
RT @sitcancer: #JITC: Safety, tumor trafficking & immunogenicity chimeric antigen receptor (CAR)-T cells for TAG-72 in colorectal https://t…
RT @sitcancer: #JITC: Safety, tumor trafficking & immunogenicity chimeric antigen receptor (CAR)-T cells for TAG-72 in colorectal https://t…
#JITC: Safety, tumor trafficking & immunogenicity chimeric antigen receptor (CAR)-T cells for TAG-72 in colorectal https://t.co/pNhGA8Osqa https://t.co/tTle0UcBjz
RT @sitcancer: #JITC: Safety, tumor trafficking & immunogenicity chimeric antigen receptor (CAR)-T cells for TAG-72 in colorectal https://t…
#JITC: Safety, tumor trafficking & immunogenicity chimeric antigen receptor (CAR)-T cells for TAG-72 in colorectal https://t.co/pNhGA8Osqa https://t.co/XjrGT00tar